Impact of Catheter Ablation on Arrhythmia Burden in Patients With Shock-Resistant Persistent Atrial Fibrillation
- PMID: 37542487
- DOI: 10.1016/j.jacep.2023.06.004
Impact of Catheter Ablation on Arrhythmia Burden in Patients With Shock-Resistant Persistent Atrial Fibrillation
Abstract
Background: Persistent shock-resistant atrial fibrillation (AF) is a challenging entity, with modest results from catheter ablation according to conventional survival analysis.
Objectives: The aim of this study was to determine the effect of catheter ablation on atrial tachyarrhythmia (ATA) burden in persistent AF patients undergoing first-time ablation with the use of an implantable cardiac monitor (ICM).
Methods: Patients with drug-resistant ongoing persistent AF and at least 1 previous failed cardioversion were implanted with an ICM 2 months before the procedure. All patients underwent pulmonary vein isolation with or without additional substrate ablation depending on the presence of self-terminating AF on ICM and left atrium size. Median AF burden before and after ablation, off antiarrhythmic medication, was determined from ICM recordings after review by 2 independent investigators.
Results: Sixty patients were recruited (mean age 66 ± 9 years, 70% male). Mean left atrial diameter was 48 ± 6 mm and median CHA2DS2VASc score was 2. Ten patients (17%) unexpectedly demonstrated self-terminating AF before ablation. The median burden of ATA before ablation was 100% (95% CI: 19.6%-100%), decreasing to 0% (95% CI: 0%-95.8%) after ablation during the post-blanking follow-up period (median reduction 100%; 95% CI: 4%-100%; P < 0.001). Twenty-seven patients (45%) experienced recurrent ATA during 12-month follow-up. In these patients, median burden before ablation was 100% (95% CI: 26.9%-100%), decreasing to 11.4% (95% CI: 0.35%-99.7%) after ablation (P < 0.001). Quality of life improved significantly from baseline, driven by lack of recurrence.
Conclusions: Patient-tailored catheter ablation results in a significant reduction in ATA burden (off antiarrhythmic medication) in shock-resistant persistent AF patients using ICMs implanted 2-months pre-procedure. These data suggest that conventional arrhythmia-free survival analysis does not capture the true impact of catheter ablation in this challenging cohort.
Keywords: atrial tachyarrhythmia burden; catheter ablation; implantable cardiac monitor; persistent atrial fibrillation; quality of life.
Copyright © 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment in
-
Catheter Ablation of Persistent Atrial Fibrillation: Are We Better Than We Think?JACC Clin Electrophysiol. 2023 Oct;9(10):2082-2084. doi: 10.1016/j.jacep.2023.07.014. Epub 2023 Sep 6. JACC Clin Electrophysiol. 2023. PMID: 37676205 No abstract available.
Similar articles
-
Long-term impact of catheter ablation on arrhythmia burden in low-risk patients with paroxysmal atrial fibrillation: The CLOSE to CURE study.Heart Rhythm. 2020 Apr;17(4):535-543. doi: 10.1016/j.hrthm.2019.11.004. Epub 2019 Nov 9. Heart Rhythm. 2020. PMID: 31707159
-
Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial.J Am Coll Cardiol. 2020 Jun 30;75(25):3105-3118. doi: 10.1016/j.jacc.2020.04.065. J Am Coll Cardiol. 2020. PMID: 32586583 Free PMC article. Clinical Trial.
-
Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.Kardiol Pol. 2013;71(1):17-24. Kardiol Pol. 2013. PMID: 23348529 Clinical Trial.
-
Impact of Catheter Ablation of Atrial Fibrillation on Disease Progression.JACC Clin Electrophysiol. 2025 Feb;11(2):421-435. doi: 10.1016/j.jacep.2024.10.017. JACC Clin Electrophysiol. 2025. PMID: 40010884 Review.
-
Effect of catheter ablation versus medical therapy on mental health and quality of life in patients with atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials.J Interv Card Electrophysiol. 2024 Nov;67(8):1905-1915. doi: 10.1007/s10840-024-01861-4. Epub 2024 Jul 9. J Interv Card Electrophysiol. 2024. PMID: 38980445
Cited by
-
Shortened radiofrequency delivery time to optimize efficiency and safety of pulmonary vein isolation with the radiofrequency balloon: insights from the COLLABORATE registry.Europace. 2024 Aug 30;26(9):euae227. doi: 10.1093/europace/euae227. Europace. 2024. PMID: 39228338 Free PMC article.
-
Catheter Ablation of Persistent AF-Where are We Now?Rev Cardiovasc Med. 2023 Nov 30;24(12):339. doi: 10.31083/j.rcm2412339. eCollection 2023 Dec. Rev Cardiovasc Med. 2023. PMID: 39077091 Free PMC article. Review.
-
Atrial Fibrillation Ablation: Impact on Burden and Cardiovascular Outcomes.J Clin Med. 2025 Apr 12;14(8):2648. doi: 10.3390/jcm14082648. J Clin Med. 2025. PMID: 40283478 Free PMC article. Review.
-
Long-term outcomes of the pentaspline pulsed-field ablation catheter for the treatment of paroxysmal atrial fibrillation: results of the prospective, multicentre FARA-Freedom Study.Europace. 2024 Mar 1;26(3):euae053. doi: 10.1093/europace/euae053. Europace. 2024. PMID: 38385529 Free PMC article.
-
Patterns of Postablation Recurrence and Adverse Cardiovascular Outcomes in Patients With Atrial Fibrillation.J Am Heart Assoc. 2025 May 6;14(9):e038832. doi: 10.1161/JAHA.124.038832. Epub 2025 Apr 17. J Am Heart Assoc. 2025. PMID: 40247625 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials